312 related articles for article (PubMed ID: 18288990)
21. Helicases as prospective targets for anti-cancer therapy.
Gupta R; Brosh RM
Anticancer Agents Med Chem; 2008 May; 8(4):390-401. PubMed ID: 18473724
[TBL] [Abstract][Full Text] [Related]
22. [General overview on DNA repair].
Pourquier P; Robert J
Bull Cancer; 2011 Mar; 98(3):229-37. PubMed ID: 21414892
[TBL] [Abstract][Full Text] [Related]
23. Curcumin suppresses multiple DNA damage response pathways and has potency as a sensitizer to PARP inhibitor.
Ogiwara H; Ui A; Shiotani B; Zou L; Yasui A; Kohno T
Carcinogenesis; 2013 Nov; 34(11):2486-97. PubMed ID: 23825154
[TBL] [Abstract][Full Text] [Related]
24. Noncoding RNAs in DNA Damage Response: Opportunities for Cancer Therapeutics.
Arjumand W; Asiaf A; Ahmad ST
Methods Mol Biol; 2018; 1699():3-21. PubMed ID: 29086365
[TBL] [Abstract][Full Text] [Related]
25. Targeting synthetic lethality in DNA damage repair pathways as an anti-cancer strategy.
Moeller BJ; Arap W; Pasqualini R
Curr Drug Targets; 2010 Oct; 11(10):1336-40. PubMed ID: 20840076
[TBL] [Abstract][Full Text] [Related]
26. MicroRNAs, DNA Damage Response, and Cancer Treatment.
He M; Zhou W; Li C; Guo M
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27973455
[TBL] [Abstract][Full Text] [Related]
27. Translesion DNA Synthesis in Cancer: Molecular Mechanisms and Therapeutic Opportunities.
Zafar MK; Eoff RL
Chem Res Toxicol; 2017 Nov; 30(11):1942-1955. PubMed ID: 28841374
[TBL] [Abstract][Full Text] [Related]
28. Cellular response to DNA damage.
Kao J; Rosenstein BS; Peters S; Milano MT; Kron SJ
Ann N Y Acad Sci; 2005 Dec; 1066():243-58. PubMed ID: 16533929
[TBL] [Abstract][Full Text] [Related]
29. DNA damage-processing pathways involved in the eukaryotic cellular response to anticancer DNA cross-linking drugs.
Beljanski V; Marzilli LG; Doetsch PW
Mol Pharmacol; 2004 Jun; 65(6):1496-506. PubMed ID: 15155842
[TBL] [Abstract][Full Text] [Related]
30. Effect of DNA repair deficiencies on the cytotoxicity of drugs used in cancer therapy - a review.
Calderón-Montaño JM; Burgos-Morón E; Orta ML; López-Lázaro M
Curr Med Chem; 2014; 21(30):3419-54. PubMed ID: 24934343
[TBL] [Abstract][Full Text] [Related]
31. MMSET/WHSC1 enhances DNA damage repair leading to an increase in resistance to chemotherapeutic agents.
Shah MY; Martinez-Garcia E; Phillip JM; Chambliss AB; Popovic R; Ezponda T; Small EC; Will C; Phillip MP; Neri P; Bahlis NJ; Wirtz D; Licht JD
Oncogene; 2016 Nov; 35(45):5905-5915. PubMed ID: 27109101
[TBL] [Abstract][Full Text] [Related]
32. Differential effects of caffeine on DNA damage and replication cell cycle checkpoints in the fission yeast Schizosaccharomyces pombe.
Osman F; McCready S
Mol Gen Genet; 1998 Nov; 260(4):319-34. PubMed ID: 9870697
[TBL] [Abstract][Full Text] [Related]
33. Role of cell cycle in mediating sensitivity to radiotherapy.
Pawlik TM; Keyomarsi K
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):928-42. PubMed ID: 15234026
[TBL] [Abstract][Full Text] [Related]
34. DNA Double Strand Breaks Repair Inhibitors: Relevance as Potential New Anticancer Therapeutics.
Kopa P; Macieja A; Galita G; Witczak ZJ; Poplawski T
Curr Med Chem; 2019; 26(8):1483-1493. PubMed ID: 29446719
[TBL] [Abstract][Full Text] [Related]
35. DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis.
Bernstein C; Bernstein H; Payne CM; Garewal H
Mutat Res; 2002 Jun; 511(2):145-78. PubMed ID: 12052432
[TBL] [Abstract][Full Text] [Related]
36. Repairing of N-mustard derivative BO-1055 induced DNA damage requires NER, HR, and MGMT-dependent DNA repair mechanisms.
Kuo CY; Chou WC; Wu CC; Wong TS; Kakadiya R; Lee TC; Su TL; Wang HC
Oncotarget; 2015 Sep; 6(28):25770-83. PubMed ID: 26208482
[TBL] [Abstract][Full Text] [Related]
37. DNA repair targeted therapy: The past or future of cancer treatment?
Gavande NS; VanderVere-Carozza PS; Hinshaw HD; Jalal SI; Sears CR; Pawelczak KS; Turchi JJ
Pharmacol Ther; 2016 Apr; 160():65-83. PubMed ID: 26896565
[TBL] [Abstract][Full Text] [Related]
38. Augmented antitumor activity by olaparib plus AZD1775 in gastric cancer through disrupting DNA damage repair pathways and DNA damage checkpoint.
Lin X; Chen D; Zhang C; Zhang X; Li Z; Dong B; Gao J; Shen L
J Exp Clin Cancer Res; 2018 Jun; 37(1):129. PubMed ID: 29954437
[TBL] [Abstract][Full Text] [Related]
39. Cellular physiology of mismatch repair.
Wu X; Khalpey Z; Cascalho M
Curr Pharm Des; 2004; 10(32):4121-6. PubMed ID: 15579092
[TBL] [Abstract][Full Text] [Related]
40. New design of nucleotide excision repair (NER) inhibitors for combination cancer therapy.
Gentile F; Tuszynski JA; Barakat KH
J Mol Graph Model; 2016 Apr; 65():71-82. PubMed ID: 26939044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
